CAS Solutions

Designed to meet the needs of research, patent, regulatory, and business professionals in every phase of the innovation journey, CAS Solutions curate, connect, and analyze scientific knowledge to reveal unseen insights and relationships that accelerate your breakthroughs.

Designed to meet the needs of research, patent, regulatory, and business professionals in every phase of the innovation journey, CAS Solutions curate, connect, and analyze scientific knowledge to reveal unseen insights and relationships that accelerate your breakthroughs.

Solutions Umbrella Abstract

SciFinder Discovery Platform

Serving the research process end-to-end

Get discoveries to market faster and optimize margins. By giving researchers the tools and information they need, you can avoid surprises, uncover competitive intelligence, and make smart investments.

Learn more about SciFinder Discovery Platform

STN IP Protection Suite

Connecting R&D and Intellectual Property

Save time and money with intellectual property (IP) insights. From new users to expert searchers, the STN IP Protection Suite helps mitigate risks and respond faster to opportunities critical to your innovation journey.

Learn more about STN IP Protection Suite

CAS Custom Services

Accelerating breakthroughs with custom data, analytics, and insight

Partner directly with expert scientists and technologists at CAS to design custom solutions that leverage our content, technology, and expertise in new ways to drive efficiency innovation, capture emerging opportunities, and solve unique R&D and business challenges.

Learn more about CAS Custom Services

Other Solutions

Mitigating risk through guidance

Drive insights that inform your scientific workflows. CAS is the specialist in scientific information, providing focused solutions for regulatory compliance, supplier information, and chemical safety.

Learn more about Other Solutions

Resources

Whitepapers

Lipid Nanoparticles: Past, Present, and Future Opportunities

Lipid nanoparticles play critical roles in mRNA vaccines for treating COVID-19, but their use is not new. Read about past, present, and future opportunities.

Press Releases

CAS Launches Significant Enhancement to Predictive Retrosynthetic Capabilities in SciFinderⁿ

CAS announces significant enhancements to the predictive retrosynthetic capabilities in SciFinderⁿ. The enhanced platform uses state-of-the-art AI technology to improve both accuracy and innovativeness of predicted results.

Whitepapers

Knowledge Graphs Accelerate COVID-19 Therapies

This whitepaper details the CAS Biomedical Knowledge Graph and shows how it was used in drug discovery for COVID-19.